A phase I/II trial investigating the safety and efficacy of autologous TAC T cells targeting HER2 in relapsed or refractory solid tumors.
- Resource Type
- Article
- Authors
- Schlechter, Benjamin L.; Olson, Daniel; Saibil, Samuel; George, Mridula Annette; Gruber, Kelly; Bouvier, Riemke; Pieke, Brooke; Geisburger, Jill; Moss, Kara M.; Ternus, Nathan; Adib, Deyaa R; Dumbrava, Ecaterina Elena
- Source
- Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, pTPS816-TPS816, 1p
- Subject
- Language
- ISSN
- 0732183X